0001243786-22-000125.txt : 20220527 0001243786-22-000125.hdr.sgml : 20220527 20220527173752 ACCESSION NUMBER: 0001243786-22-000125 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220427 FILED AS OF DATE: 20220527 DATE AS OF CHANGE: 20220527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Rourke James Calvin CENTRAL INDEX KEY: 0001453221 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32327 FILM NUMBER: 22979305 MAIL ADDRESS: STREET 1: C/O THE MOSAIC COMPANY STREET 2: 101 EAST KENNEDY BLVD., SUITE 2500 CITY: TAMPA STATE: FL ZIP: 33602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOSAIC CO CENTRAL INDEX KEY: 0001285785 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 201026454 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 EAST KENNEDY BLVD. STREET 2: SUITE 2500 CITY: TAMPA STATE: FL ZIP: 33602 BUSINESS PHONE: 813-775-4200 MAIL ADDRESS: STREET 1: 101 EAST KENNEDY BLVD. STREET 2: SUITE 2500 CITY: TAMPA STATE: FL ZIP: 33602 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL NUTRITION SOLUTIONS INC DATE OF NAME CHANGE: 20040401 4 1 wf-form4_165368745615297.xml FORM 4 X0306 4 2022-04-27 0 0001285785 MOSAIC CO MOS 0001453221 O'Rourke James Calvin C/O THE MOSAIC COMPANY 101 EAST KENNEDY BLVD., SUITE 2500 TAMPA FL 33602 1 1 0 0 President & CEO Common Stock 2022-04-27 5 G 0 E 13295 0 D 0 I By 2019 GRAT dated April 1, 2019 Common Stock 2022-04-27 5 G 0 E 13295 0 A 148515 D Common Stock 2022-05-25 5 G 0 E 143742 0 D 0 I By 2020 GRAT dated May 21, 2020 Common Stock 2022-05-25 5 G 0 E 25672 0 A 174187 D Common Stock 2022-05-25 5 G 0 E 174187 0 D 0 D Common Stock 2022-05-25 5 G 0 E 174187 0 A 174187 I 2022 GRAT 2A dated April 22, 2022 Common Stock 130294 I By 2021 GRAT 2 dated June 30, 2021 Common Stock 23128 I By 2021 GRAT 3 dated June 30, 2021 Common Stock 3000 I Reporting Person's Spouse Stock Option (Right to Buy) 54.03 2023-07-18 Common Stock 29987.0 29987 D Stock Option (Right to Buy) 49.73 2024-03-07 Common Stock 33706.0 33706 D Stock Option (Right to Buy) 50.43 2025-03-05 Common Stock 37306.0 37306 D Stock Option (Right to Buy) 28.49 2026-03-03 Common Stock 179211.0 179211 D Stock Option (Right to Buy) 30.42 2027-03-02 Common Stock 168180.0 168180 D Restricted Stock Units 0.0 2023-03-05 Common Stock 121989.0 121989 D Restricted Stock Units 0.0 2024-03-04 Common Stock 83418.0 83418 D Restricted Stock Units 0.0 2025-03-03 Common Stock 56773.0 56773 D On April 27, 2022, the reporting person indirectly held 13,295 shares of MOS common stock ("2019 GRAT Shares") in a grantor retained annuity trust for the benefit of himself and his spouse ("2019 GRAT"). On that date and upon termination of the 2019 GRAT, the 2019 GRAT Shares were distributed to the reporting person in satisfaction of an annuity due to the reporting person and was exempt from reporting under Rule 16a-13. On May 25, 2022, the reporting person indirectly held 143,742 shares of MOS common stock ("2020 GRAT Shares") in a grantor retained annuity trust for the benefit of himself and his spouse ("2020 GRAT"). On that date and upon termination of the 2020 GRAT, 118,070 of the 2020 GRAT Shares were distributed to the James C. O'Rourke Grantor Investment Trust of 2019 for the benefit of the reporting person's adult children, which distribution was exempt from reporting under rule 16b-5; and 25,672 of the 2020 GRAT Shares shares were distributed to the reporting person in satisfaction of an annuity due to the reporting person and was exempt from reporting under Rule 16a-13. This transaction involved a gift of MOS common stock by the reporting person to a grantor retained annuity trust dated April 22, 2022, for the benefit of reporting person and his spouse ("2022 GRAT 2A"). The reporting person serves as trustee of the 2022 GRAT 2A. This Stock Option is 100% exercisable. One-for-One Not Applicable /s/ Mark J. Isaacson, Attorney-in-Fact for James C. O'Rourke 2022-05-27